Abbott approves $3 billion share buyback

SHARE Abbott approves $3 billion share buyback

Abbott Laboratories said Thursday its board approved spending up to $3 billion to buy back the health conglomerate’s stock.

The company, which makes Similac infant formula, medical devices and pharmaceutical drugs, said it will by stock from time to time depending on market conditions. It still has buyback authority to repurchase $511 million in shares from a buyback it announced in June 2013.

North Chicago-based Abbott also approved a dividend of 22 cents that will be paid on Nov. 15 to shareholders of record as of Oct. 15.

Abbott shares slipped 39 cents to $42.51 in afternoon trading Thursday. Its shares had risen more than 22 percent over the past year.


Abbott raises profit outlook

Abbott sells part of generic drugs business to Mylan for $5.3B

Abbott, Fonterra team up on China dairy farm

THE ASSOCIATED PRESS

The Latest
The joint statement is the latest attempt at public pressure to advance negotiations over a potential cease-fire with Israel.
A news release from NU Educators for Justice in Palestine, Student Liberation Union and Jewish Voice for Peace said the camp is meant to be “a safe space for those who want to show their support of the Palestinian people.”
Powerhouse showcase is part of a weekend of music events planned for Grant Park’s Festival Field great lawn, which also features previously announced sets by Keith Urban, the Chainsmokers, the Black Keys and Lauren Alaina.
Last year, Black and Brown residents, Muslim Americans, Jewish Americans, members of the LGBTQ+ community and others were targeted in hate crimes more than 300 times. Smart new policies, zero tolerance, cooperation and unity can defeat hate.
The city is willing to put private interests ahead of public benefit and cheer on a wrongheaded effort to build a massive domed stadium — that would be perfect for Arlington Heights — on Chicago’s lakefront.